Schedule 13G ownership disclosure
AEON Biopharma, Inc.
Security class unavailable · CUSIP: 00791X100
Event date: 2023-07-27
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,675,000
- Percent of class
- 9.8900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001041062-23-000142
- Form type
- SC 13G
- Filer
- AEON Biopharma, Inc.
- CIK
- CIK 1837607
- Filed
- Jul 31, 2023
- Reporting period
- Jul 27, 2023
- Description
- Schedule 13G beneficial ownership